Literature DB >> 12095621

Quantification of NF1 transcripts reveals novel highly expressed splice variants.

Ina Vandenbroucke1, Jo Vandesompele, Anne De Paepe, Ludwine Messiaen.   

Abstract

Previously, we have shown that the NF1 gene gives rise to multiple novel splice variants. In the present study, nine NF1 variants were quantified by real-time PCR in various human tissues. Some of these variants were expressed at low to moderate low levels and possible implications of these findings are discussed. Interestingly, two variants (NF1-DeltaE4b and NF1-DeltaE43) were shown to be highly expressed in specific tissues. NF1-DeltaE43 lacks a nuclear targeting sequence and might be functionally different from full-length NF1. These novel NF1 splice variants might expand our understanding of the role of neurofibromin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095621     DOI: 10.1016/s0014-5793(02)02887-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Reduced growth of Drosophila neurofibromatosis 1 mutants reflects a non-cell-autonomous requirement for GTPase-Activating Protein activity in larval neurons.

Authors:  James A Walker; Anna V Tchoudakova; Peter T McKenney; Suzanne Brill; Dongyun Wu; Glenn S Cowley; Iswar K Hariharan; André Bernards
Journal:  Genes Dev       Date:  2006-11-17       Impact factor: 11.361

2.  Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.

Authors:  Jessica J Hawes; Robert G Tuskan; Karlyne M Reilly
Journal:  Neurogenetics       Date:  2007-01-11       Impact factor: 2.660

Review 3.  Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.

Authors:  Justin Korfhage; David B Lombard
Journal:  Mol Cancer Res       Date:  2019-04-25       Impact factor: 5.852

Review 4.  The pathoetiology of neurofibromatosis 1.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Anthony M Heape; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

5.  Functional analysis of splicing mutations in exon 7 of NF1 gene.

Authors:  Irene Bottillo; Alessandro De Luca; Annalisa Schirinzi; Valentina Guida; Isabella Torrente; Stefano Calvieri; Cristina Gervasini; Lidia Larizza; Antonio Pizzuti; Bruno Dallapiccola
Journal:  BMC Med Genet       Date:  2007-02-12       Impact factor: 2.103

6.  Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations.

Authors:  Navneet Sangha; Rong Wu; Rork Kuick; Scott Powers; David Mu; Diane Fiander; Kit Yuen; Hidetaka Katabuchi; Hironori Tashiro; Eric R Fearon; Kathleen R Cho
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

7.  Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.

Authors:  Steven Yea; Goutham Narla; Xiao Zhao; Rakhi Garg; Sigal Tal-Kremer; Eldad Hod; Augusto Villanueva; Johnny Loke; Mirko Tarocchi; Kunihara Akita; Senji Shirasawa; Takehiko Sasazuki; John A Martignetti; Josep M Llovet; Scott L Friedman
Journal:  Gastroenterology       Date:  2008-02-13       Impact factor: 22.682

8.  NF1 exon 7 skipping and sequence alterations in exonic splice enhancers (ESEs) in a neurofibromatosis 1 patient.

Authors:  Patrizia Colapietro; Cristina Gervasini; Federica Natacci; Livia Rossi; Paola Riva; Lidia Larizza
Journal:  Hum Genet       Date:  2003-09-06       Impact factor: 4.132

9.  Cyclic stretch increases splicing noise rate in cultured human fibroblasts.

Authors:  Michael Uhl; Kevin Mellert; Britta Striegl; Martin Deibler; Markus Lamla; Joachim P Spatz; Ralf Kemkemer; Dieter Kaufmann
Journal:  BMC Res Notes       Date:  2011-10-31

10.  Prediction of alternatively skipped exons and splicing enhancers from exon junction arrays.

Authors:  Katerina Kechris; Yee Hwa Yang; Ru-Fang Yeh
Journal:  BMC Genomics       Date:  2008-11-20       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.